EXCRETION OF 1-HEXYLCARBAMOYL-5-FLUOROURACIL IN URINE OF MICE
スポンサーリンク
概要
- 論文の詳細を見る
Excretion and metabolites in urine and feces of mice after oral administration of 1-hexylcarbamoyl-5-fluorouracil-6-^<14>C (^<14>C-HCFU) or 5-fluorouracil-6-^<14>C (^<14>C-FU) were examined. After oral administration, about 90% of ^<14>C-HCFU was excreted in urine within 48 h but not in feces. Major radioactive compounds in urine were 1-(3-carboxypropylcarbamoyl)-5-fluorouracil (CPRFU), FU, 5,6-dihydro-5-fluorouracil (DHFU) and α-fluoro-β-alanine (FBAL). Excretion ratio of these metabolites within 48 h was 13.5,32.5,20.2 and 23.9%, respectively, CPRFU and FU were rapidly excreted in urine after ^<14>C-HCFU administration followed by DHFU and FBAL. Excretion of the latter two degradation products of FU was slower. On the other hand, major metabolites in urine after ^<14>C-FU administration were DHFU and FBAL, but intact FU was slightly excreted. Excretion ratio of FU, DHFU and FBAL within 48 h was 4.8,58.1 and 28.2%, respectively.
- 公益社団法人日本薬学会の論文
著者
-
Hoshi Akio
Pharmacology Division National Cancer Center Research Institute
-
Hoshi Akio
国立がんセンター
-
Hoshi A
National Cancer Center Resarch Institute
-
Iigo M
National Cancer Res. Inst. Tokyo
-
Iigo Masaaki
Cancer Prevention Basic Res. Project National Cancer Center Res. Inst.
-
Iigo Masaaki
Pharmacology Division National Cancer Center Research Institute
-
Iigo Masaaki
Experimental Pathology And Chemotherapy Division National Cancer Center Research Institute
-
Kuretani Kazuo
Pharmacology Division National Cancer Center Research Institute
-
Hoshi Akio
Pharmaceutical Development Laboratories Meiji Seika Kaisha Ltd. : Central Research Laboratories Meij
-
Ishiguro Masaji
Loboratory Of Chemistry For Natural Products Tokyo Institute Of Technology
-
NAKAMURA ASAKO
Pharmacology Division, National Cancer Center Research Institute
-
Nakamura Asako
Pharmacology Division National Cancer Center Research Institute
関連論文
- 5-Fluorouracil Derivatives. XXII. Synthesis and Antitumor Activities of 1-Carbamoyl-5-fluorouracils
- 5-Fluorouracil Derivatives. XII. : Synthesis and Antitumor Activity of α-Alkylthiomethyl-, α-Alkylsulfinylmethyl-, α-Alkylsulfonylmethyl-, and α-Acylthiomethyl-5-fluorouracils(Medeicinal Chemistry,Chemical)
- Quantification of 5-fluorouracil and its metabolites in human serum, using liquid chromatography-mass spectrometry
- Decreased Levels of 2-Amino-3-methylimidazo[4,5-f]quinoline-DNA Adducts in Rats Treated with β-Carotene, α-Tocopherol and Freeze-dried Aloe
- Prevention of carcinogenesis and cancer metastasis by bovine lactoferrin
- ANTITUMOR ACTIVITY OF 1-ACYLOXYMETHYL DERIVATIVES OF 5-FLUOROURACIL AGAINST L1210 LEUKEMIA
- ANTITUMOR ACTIVITY OF ALKYLDISULFIDE DERIVATIVES OF 6-MERCAPTOPURINES AGAINST L-1210 LEUKEMIA
- ANTITUMOR ACTIVITY OF 1-ALKOXYCARBONYLALKYLCAR-BAMOYL-5-FLUOROURACIL DERIVATIVES BY ORAL ADMINISTRATION
- STRUCTURE-ANTITUMOR ACTIVITY RELATIONSHIP OF PURIN-6-YL ALKYL DISULFIDES
- ANTITUMOR ACTIVITY OF DERIVATIVES OF NEPLANOCIN A IN VIVO AND IN VITRO
- ISOLATION AND CHARACTERIZATION OF THE MURINE LYMPHOMA L5178Y CELL LINE HIGHLY RESISTANT TO 5-FLUOROURACIL
- THE DIFFERENCE IN MECHANISM OF ACTION OF 5-FLUOROURACIL AND ITS NUCLEOSIDES IN L5178Y CELLS
- A Simple Method for Predicting Modes of Actions of Antitumor Agents
- POTENTIATION OF ANTITUMOR ACTIVITY OF 5-FLUORO-2', DEOXYURIDINE BY GUANOSINE-5'-MONOPHOSPHATE
- ANTITUMOR ACTIVITY OF ALKYLESTERS OF 5-FLUORO-2'-DEOXYURIDINE 5'-MONOPHOSPHATE (FDUMP) AGAINST MURINE LYMPHOMA L5178Y RESISTANT TO 5-FLUORO-2'-DEOXYURIDINE
- Isoliquiritigenin, a flavonoid from licorice, reduces prostaglandin E_2 and nitric oxide, causes apoptosis, and suppresses aberrant crypt foci development
- Down-regulation of 2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx)-induceed CYP1A2 Expression Is Associated with Bovine Lactoferrin Inhibition of MeIQx-induced Liver and Colon Carcinogenesis in Rats
- Organotropic Chemopreventive Effects of n-3 Unsaturated Fatty Acids in a Rat Multi-organ Carcinogenesis Model
- Establishment and characterization of three new rat renal cell carcinoma cell lines from N-ethyl-N-hydroxyethylnitrosamine-induced basophilic cell tumors
- Activation of Intestinal Mucosal Immunity in Tumor-bearing Mice by Lactoferrin
- Possible Chemopreventive Effects of Bovine Lactoferrin on Esophagus and Lung Carcinogenesis in the Rat
- Cancer Prevention by Natural Compounds
- IMPROVEMENT OF THERAPEUTIC EFFECT OF 5-FLUOROURACIL BY OROTIC ACID
- EFFECT OF PYRIMIDINES, PURINES AND THEIR NUCLEOSIDES ON ANTITUMOR ACTIVITY OF 5-FLUOROURACIL AGAINST L-1210 LEUKEMIA
- EXCRETION OF 1-HEXYLCARBAMOYL-5-FLUOROURACIL IN URINE OF MICE
- ANTITUMOR ACTIVITY OF METABOLITES OF 1-HEXYLCAR-BAMOYL-5-FLUOROURACIL AND RELATED COMPOUNDS AGAINST L1210 LEUKEMIA IN VIVO AND L5178Y LYMPHOMA CELLS IN VITRO
- RELATIONSHIP BETWEEN CHEMICAL STRUCTURE AND ANTITUMOR ACTIVITY OF WITHAFERIN A ANALOGUES
- DISTRIBUTION OF 1-HEXYLCARBAMOYL-5-FLUOROURACIL AND 5-FLUOROURACIL BY ORAL ADMINISTRATION IN MICE
- ANTITUMOR ACTIVITY OF 1-HEXYLCARBAMOYL-5-FLUOROURACIL IN LEWIS LUNG CARCINOMA AND B16 MELANOMA
- FURTHER STUDY ON THE RELATION BETWEEN AREA AND DESOXYRIBONUCLEIC ACID CONTENT OF THE MAMMARY GLAND IN MICE
- Synergistic inhibition of the growth of adenocarcinoma 755 by the combination of interleukin-2 and interferon-.BETA..